VC_Biotech_Biopure01

BT_Biopure

Company: BioPure
Industry: Pharmaceuticals
Investors: New Enterprise Associates, Aspen Ventures, Earl Kinship, Braun Melsungen AG, Upjohn, Bain Capital, Dreyfus, Parmacia AB, Oaktree Capital Management, New England Partners and RMG.

The mission of Biopure Corporation (Nasdaq: BPUR) is to introduce revolutionary new drugs that deliver lifesaving oxygen. Using its patented and proprietary technology, Biopure has pioneered the development and manufacture of oxygen therapeutics, a new class of pharmaceuticals that are intravenously administered to deliver oxygen to the body’s tissues. The company’s products represent a new Oxygen Bridgeâ„¢ treatment approach for managing patients’ oxygen requirements in potential medical applications associated with ischemia or acute anemia.

www.biopure.com